Celldex Therapeutics
CLDX
$36.30
Share price
0.11%
Change (1 day)
12.28%
Change (1 year)
Categories
Celldex Therapeutics (CLDX) - Net assets
Net assets on the balance sheet as of December 2023 : $0.42 B
According to Celldex Therapeutics's latest financial reports the company has $0.42 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.42 B | 31.57% |
| 2022-12-31 | $0.32 B | -22.24% |
| 2021-12-31 | $0.41 B | 100.36% |
| 2020-12-31 | $0.20 B | 122.66% |
| 2019-12-31 | $94.02 M | -24.21% |
| 2018-12-31 | $0.12 B | -47.51% |
| 2017-12-31 | $0.23 B | -10.95% |
| 2016-12-31 | $0.26 B | -8.51% |
| 2015-12-31 | $0.29 B | 37.06% |
| 2014-12-31 | $0.21 B | -33.81% |
| 2013-12-31 | $0.31 B | 233.91% |
| 2012-12-31 | $95.77 M | 39.36% |
| 2011-12-31 | $68.72 M | -8.68% |
| 2010-12-31 | $75.25 M | 2.02% |
| 2009-12-31 | $73.76 M | 306.79% |
| 2008-12-31 | $18.13 M | -1702.09% |
| 2007-12-31 | $-1.14 M | -152.38% |
| 2006-12-31 | $2.16 M | -89.65% |
| 2005-12-31 | $20.88 M | -45.61% |
| 2004-12-31 | $38.4 M | 37.56% |
| 2003-12-31 | $27.91 M | -10.93% |
| 2002-12-31 | $31.34 M | -30.76% |
| 2001-12-31 | $45.26 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 20,704.76% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 1,352.10% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 3,695.22% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $8.13 M | -98.10% | 🇺🇸 USA |
 Seagen
SGEN | $2.55 B | 494.27% | 🇺🇸 USA |
 Agenus
AGEN | -$0.15 B | -134.57% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.64 B | 51.29% | 🇺🇸 USA |